GENEMEDICS APP
GENEMEDICS NUTRITION
According to studies, cabergoline has direct beneficial effects on blood sugar levels and in diabetic patients:
1. In type 2 diabetic patients who do not respond to anti-diabetic medications, cabergoline treatment reduced fasting and postprandial plasma glucose levels as well as glycosylated hemoglobin (HbA1c). [44]
2. Three months of cabergoline treatment also decreased HbA1C in type 2 diabetic patients. [45]
3. Six months of cabergoline treatment among patients with high prolactin levels resulted in significant reduction in plasma glucose. [46]
4. In patients with benign noncancerous tumor of the pituitary gland, cabergoline administration for 6 months caused an improvement in insulin sensitivity and inflammatory markers. [47]
5. In patients with prediabetes, cabergoline administration at a dose of 0.25 mg twice weekly for two weeks improved glucose metabolism. [48]
6. In patients with hyperprolactinemia, normalization of elevated prolactin levels by cabergoline treatment was accompanied by reduction in plasma glucose levels. [49]
Call 800-277-4041 for a Free Consultation